Levofloxacin simulant

PreclinicalSmall molecule

YYi Yang

Levofloxacin simulant is one of 37 small molecule programs targeting Ischemic stroke. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ischemic StrokeActive, not recruiting

Ischemic StrokePreclinical

Active, not recruiting

Competition

Competitive Landscape

116 competitors in Ischemic Stroke

#DrugCompanyPhaseTrials

Reminyl

WWim Janssens

Phase 3

1 2

Atorvastatin Calcium

Merck & Co.

Phase 3

1 3

Butylphthalide

PPeking Union Medical College Hospital

Phase 3

3 4

PCSK9 Inhibitor

YYun Dai Chen

Phase 3

3 5

Tegoprazan

SShandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Phase 3

1 6

Edaravone Dexborneol

SSimcere Pharmaceutical Co., Ltd

Phase 3

9 7

Tenecteplase or Alteplase

IInsel Gruppe AG, University Hospital Bern

Phase 3

2 8

Proamatine

Takeda

Preclinical

2 9

Levaquin

WWim Janssens

Preclinical

3 10

Tylenol

KKenvue Brands

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ischemic stroke3 trials

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

Recruiting·YYi Yang·N/A·NCT05799326·100 enrolled

Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke

Not yet recruiting·YYi Yang·N/A·NCT05743101·80 enrolled

Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke

Recruiting·YYi Yang·N/A·NCT05741905·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Levofloxacin simulant. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Levofloxacin simulant compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Levofloxacin simulant. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yi Yang company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: YYi Yang

Levofloxacin simulant

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ischemic stroke3 trials

References

Drug Info

Quick Facts

Related News